会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Organic electroluminescent light source
    • 有机电致发光光源
    • US08502440B2
    • 2013-08-06
    • US12989196
    • 2009-04-10
    • Hiroyasu InoueHirotoshi Tanimoto
    • Hiroyasu InoueHirotoshi Tanimoto
    • H01L51/50
    • H01L51/5268H01L51/524H01L51/5271
    • An organic electroluminescent light source device includes, in the following order from a light-emitting surface side, a first transparent electrode layer, a luminescent layer, a second transparent electrode layer, and a reflecting layer, wherein the reflecting layer includes a concavo-convex structure with an average inclination angle of 12 to 45°. An organic electroluminescent light source device includes, in the following order, a first transparent electrode layer, a luminescent layer, a second transparent electrode layer, a diffusing layer, and a reflecting-scattering layer, wherein the diffusing layer has a concavo-convex surface including a concavo-convex structure with an average inclination angle of 17 to 45°.
    • 一种有机电致发光光源装置,从发光面侧依次包括第一透明电极层,发光层,第二透明电极层和反射层,其中反射层包括凹凸 平均倾角为12〜45°的结构。 有机电致发光光源装置按照以下顺序包括第一透明电极层,发光层,第二透明电极层,漫射层和反射散射层,其中漫射层具有凹凸表面 包括平均倾斜角为17°〜45°的凹凸结构。
    • 2. 发明申请
    • ORGANIC ELECTROLUMINESCENT LIGHT SOURCE
    • 有机电致发光源
    • US20110050082A1
    • 2011-03-03
    • US12989196
    • 2009-04-10
    • Hiroyasu InoueHirotoshi Tanimoto
    • Hiroyasu InoueHirotoshi Tanimoto
    • H01J1/62
    • H01L51/5268H01L51/524H01L51/5271
    • An organic electroluminescent light source device includes, in the following order from a light-emitting surface side, a first transparent electrode layer, a luminescent layer, a second transparent electrode layer, and a reflecting layer, wherein the reflecting layer includes a concavo-convex structure with an average inclination angle of 12 to 45°. An organic electroluminescent light source device includes, in the following order, a first transparent electrode layer, a luminescent layer, a second transparent electrode layer, a diffusing layer, and a reflecting-scattering layer, wherein the diffusing layer has a concavo-convex surface including a concavo-convex structure with an average inclination angle of 17 to 45°.
    • 一种有机电致发光光源装置,从发光面侧依次包括第一透明电极层,发光层,第二透明电极层和反射层,其中反射层包括凹凸 平均倾角为12〜45°的结构。 有机电致发光光源装置按照以下顺序包括第一透明电极层,发光层,第二透明电极层,漫射层和反射散射层,其中漫射层具有凹凸表面 包括平均倾斜角为17°〜45°的凹凸结构。
    • 9. 发明授权
    • Antibody kit for the detection of TADG-15 protein
    • 用于检测TADG-15蛋白的抗体试剂盒
    • US07022821B1
    • 2006-04-04
    • US09421213
    • 1999-10-20
    • Timothy J. O'BrienHirotoshi Tanimoto
    • Timothy J. O'BrienHirotoshi Tanimoto
    • C07K16/00C07K1/00C07K14/00C07K17/00C12P21/08
    • C12N9/6424A61K39/00C12Q1/6851C12Q1/6886C12Q2600/136Y10T436/25
    • The present invention provides DNA encoding a TADG-15 protein as well as a TADG-15 protein. Also provided is a vector capable of expressing the DNA of the present invention adapted for expression in a recombinant cell and regulatory elements necessary for expression of the DNA in the cell. The present invention further provides for methods of inhibiting TADG-15 expression and/or protease activity, methods of detecting TADG-15 mRNA and/or protein and methods of screening for TADG-15 inhibitors. Additionally, the present invention provides for cell-specific targeting via TADG-15 and methods of vaccinating an individual against TADG-15. The instant invention also includes a kit containing antibodies for the detection of TADG-15 protein. The methods described are useful in the diagnosis, treatment and prevention of cancer, particularly breast and ovarian cancer.
    • 本发明提供编码TADG-15蛋白质和TADG-15蛋白质的DNA。 还提供了能够表达适于在重组细胞中表达的本发明的DNA的载体和在细胞中表达DNA所需的调节元件。 本发明还提供了抑制TADG-15表达和/或蛋白酶活性的方法,检测TADG-15mRNA和/或蛋白质的方法以及筛选TADG-15抑制剂的方法。 另外,本发明提供了通过TADG-15进行的细胞特异性靶向和针对TADG-15接种个体的方法。 本发明还包括含有用于检测TADG-15蛋白的抗体的试剂盒。 所描述的方法可用于诊断,治疗和预防癌症,特别是乳腺癌和卵巢癌。
    • 10. 发明授权
    • TADG-15: an extracellular serine protease overexpressed in carcinomas
    • TADG-15:细胞外丝氨酸蛋白酶在癌中过表达
    • US06649741B1
    • 2003-11-18
    • US09654600
    • 2000-09-01
    • Timothy J. O'BrienHirotoshi Tanimoto
    • Timothy J. O'BrienHirotoshi Tanimoto
    • C07K1600
    • C12N9/6424A61K39/00C12Q1/6851C12Q1/6886C12Q2600/136Y10T436/25
    • The present invention provides DNA encoding a TADG-15 protein as well as a TADG-15 protein. Also provided is a vector capable of expressing the DNA of the present invention adapted for expression in a recombinant cell and regulatory elements necessary for expression of the DNA in the cell. The present invention further provides for methods of inhibiting TADG-15 expression and/or protease activity methods of detecting TADG-15 mRNA and/or protein and methods of screening for TADG-15 inhibitors. Additionally, the present invention provides for cell-specific targeting via TADG-15 and methods of vaccinating an individual against TADG-15. The methods described are useful in the diagnosis. treatment and prevention of cancer particularly breast and ovarian cancer.
    • 本发明提供编码TADG-15蛋白质和TADG-15蛋白质的DNA。 还提供了能够表达适于在重组细胞中表达的本发明的DNA的载体和在细胞中表达DNA所需的调节元件。 本发明还提供了抑制TADG-15 mRNA和/或蛋白质的TADG-15表达和/或蛋白酶活性检测方法以及筛选TADG-15抑制剂的方法。 另外,本发明提供了通过TADG-15进行的细胞特异性靶向和针对TADG-15接种个体的方法。 所述方法在诊断中是有用的。 治疗和预防癌症,特别是乳腺癌和卵巢癌。